NASDAQ · Medical - Devices

SNWV (SNWV) Stock

$5.97 -1.49% NASDAQ: SNWV Healthcare

Valuation

MetricValue
Price$5.97
Market Cap$51.34M
P/E Ratio45.61
P/B Ratio80.36
P/S Ratio3.15
EPS (TTM)$0.41
52-Week High$46.59
52-Week Low$5.84
Dividend Yield—

Financials & Margins

MetricValue
ROE600.00%
ROA32.43%
ROCE500.00%
Gross Margin11.36%
Operating Margin11.36%
Net Margin26.82%
Debt/Equity14.19
Current Ratio1.39

Annual Financials (USD)

Metric20212022202320242025
Revenue$13.0M$17.0M$20.0M$33.0M$44.0M
Operating Profit$-14.0M$-9.0M$-1.0M$5.0M$5.0M
Net Profit$-27.0M$-10.0M$-26.0M$-31.0M$12.0M
EPS$-19.72$-7.02$-12.19$-7.03$0.41
Op Margin-108.7%-53.5%-2.6%16.6%11.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$19.0M$20.0M$22.0M$30.0M$37.0M
Total Liabilities$58.0M$61.0M$66.0M$43.0M$36.0M
Cash$1.0M$1.0M$2.0M$10.0M$12.0M
Borrowings$28.0M$39.0M$30.0M$25.0M$23.0M

Latest News

Sanuwave Health's Preliminary Q2 Revenue Tops Revised Guidance MT Newswires · Jul 13, 2026 Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance GlobeNewswire · Jul 13, 2026 Top Midday Decliners MT Newswires · Jun 16, 2026 Sanuwave Health Updates Second Quarter 2026 Guidance GlobeNewswire · Jun 16, 2026 SANUWAVE Health Inc (SNWV) Q1 2026 Earnings Call Highlights: Record Revenue Amid Market Challenges GuruFocus.com · May 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-6.0M$-17.0M$-5.0M$2.0M$4.0M
Investing Cash Flow$-1.0M$1.0M$0$-1.0M$1.0M
Financing Cash Flow$2.0M$1.0M$-1.0M$-1.0M$0
Net Cash Flow$-2.0M$1.0M$1.0M$8.0M$2.0M
Free Cash Flow$-7.0M$-16.0M$-5.0M$2.0M$2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA28.62
FCF Yield1.24%
Quick Ratio1.06
Interest Coverage0.83
Return 1Y-73.91%
Return 3Y—
Return 5Y—

Ownership

Insiders Held1.31%
Institutions Held47.20%
Institutions Float Held47.82%
Institutional HolderSharesReport Date
Opaleye Management Inc.981,2672026-03-31
Blackrock Inc.481,5402026-03-31
AWM Investment Company, Inc.454,5502026-03-31
Praetorian PR LLC350,0002026-03-31
Vanguard Capital Management LLC348,8742026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
FHTXFoghorn Therapeutics Inc. $5.20 +7.22% -4.15 $305.31M 0.00%
HSDT $1.69 +0.60% -1.25 $98.67M 0.00%
IMRX $4.24 -2.75% -3.94 $153.92M 0.00%
INGN $6.49 +1.09% -8.00 $175.71M 0.00%
MASS $8.30 -1.31% 12.81 $340.53M 0.00%

About SNWV

SNWV is led by CEO Morgan C. Frank, publicly traded since 2009.

SNWV stock trades at $5.97 with a market capitalization of $51.34M. The stock is valued at a price-to-earnings (P/E) ratio of 45.61, price-to-book of 80.36, price-to-sales of 3.15. Over the past 52 weeks the stock has ranged between $5.84 and $46.59, and currently trades 87.2% below its 52-week high.

On profitability, SNWV generates a return on equity (ROE) of 600.00% — well above the market average, a sign of a high-quality business, return on capital employed of 500.00%, an operating margin of 11.36%, a net profit margin of 26.82%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides